Assessing the Predictive Power of PIRCHE-II Scores for the Development of <i>De Novo</i> Donor-Specific Antibodies After Simultaneous Pancreas-Kidney Transplantation.

Transpl Int · 2024 · PMC11688186 · PMID 39744043

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Development of dnDSA in SPKTRs and KTRs Overall, SPKTRs showed a trend towards a higher incidence of dnDSA compared to KTRs over the whole observation period. 16/72 (22%) SPKTRs developed dnDSA ( Table 2 ) as compared to 59 of 383 (15%) KTRs.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Assessing the Predictive Power of PIRCHE-II Scores for the Development of &lt;i&gt;De Novo&lt;/i&gt; Donor-Specific Antibodies After Simultaneous Pancreas-Kidney Transplantation.

The sentences

Assessing the Predictive Power of PIRCHE-II Scores for the Development of <i>De Novo</i> Donor-Specific Antibodies After Simultaneous Pancreas-Kidney Transplantation.